Mission to the World Trade Organization, policy director to Senator Bob Dole, and adjunct professor at Georgetown University
Saito A, Suzuki Y, Kitamura M, Ogata S, Yoshihara Y, Masuda S, et al
Elevate Health currently offers three main medication options: compounded semaglutide (marketed as their GLP-1 option), compounded tirzepatide (marketed as their GLP/GIP option), and brand-name Zepbound (FDA-approved tirzepatide)
The FTC took action against telemedicine company NextMed, alleging it exploited consumer interest in GLP-1 drugs by selling weight-loss programs with undisclosed costs and membership commitments, making unsubstantiated claims about client weight loss, using fake testimonials, and unfairly distorting consumer reviews
TB500 systemic healing and improved cellular regeneration
The DAC (drug affinity complex) conjugation extends half-life from 30 minutes to 68 days, which is what makes twice-weekly dosing viable